Chip localization has become the focus, the industry: speed up the localization of pharmaceutical equipment is also imminent

"Pharmaceutical network market analysis" recently, chip localization can be said to be the focus of domestic attention, but also caused a hot discussion of drug machines.
, some drug machine people believe that "accelerating the localization of pharmaceutical equipment is also imminent, Huawei is a former car."
" pharmaceutical equipment (Photo: Pharmaceutical Network) manufacturing industry, especially equipment manufacturing industry high-quality development is China's economic high-quality development of the top priority.
pharmaceutical equipment manufacturing industry as an important part of equipment manufacturing industry, but also need to move towards high-quality, self-support direction.
Pharmaceutical equipment industry status quo: lack of core technology, lack of competitiveness of domestic equipment at present, on the development of China's pharmaceutical equipment industry, the domestic pharmaceutical equipment industry has been able to basically meet the domestic market demand, while the size of overseas markets is also expanding, the average annual export delivery value growth rate of more than 20%.
According to the "2020-2024 Pharmaceutical Equipment Industry In-depth Market Research and Investment Strategy Recommendation Report" released by the New Think Industry Research Center, at present, domestic pharmaceutical equipment in the low-end market has basically achieved import substitution, but in the high-end market needs to further strengthen the breakthrough.
, in the middle and low-end areas, the advantages of domestic products are obvious, generally rely on low-cost competition in the market.
high-end areas, such as centrifuges and other products, basically by imported brands monopolize the market.
overall, the technical level and stability of domestic pharmaceutical equipment still need to be improved.
reasons behind this analysis, the lack of core technology is the whole domestic pharmaceutical equipment industry on the road of high-quality development of the "card neck" problem.
Because domestic pharmaceutical equipment enterprises are mainly small and medium-sized, independent innovation ability is not strong, in research and development investment is also lack of enthusiasm, so that product technology and quality in the high-end market competitive advantage is not obvious.
Looking to the future of the industry: the development space is large, two short boards need to be complemented by drug machine people pointed out that in the collection and collection of a series of pharmaceutical policies, as well as the impact of rising costs of pharmaceutical companies, the domestic pharmaceutical equipment industry still has a larger space for development.
the challenge is how to build core technology and core competitiveness, how to quickly and effectively establish brand status, industry enterprises know how to divide labor and collaborate to highlight their respective advantages.
, the pharmaceutical industry is facing the challenges of reducing costs and expanding production capacity under the influence of policies such as mining and consistency evaluation.
believes that for pharmaceutical equipment enterprises, to improve the continuity of equipment, automation, information technology level, and can provide pharmaceutical companies with complete solutions, is the urgent task of enterprise development.
At the same time, so that domestic equipment out of the country, China's pharmaceutical equipment industry to strengthen the international strategic layout, through technical efforts to achieve the ability to compete with imported brands, expand the market scope, the establishment of international brands is another countermeasure of domestic pharmaceutical equipment enterprises.
In addition, it has been suggested that, at present, pharmaceutical equipment enterprises should seize the opportunity for the state to strengthen research and development of core technologies and key components manufacturing, and cooperate in-depth with universities and scientific research institutions to promote the development of pharmaceutical equipment manufacturing industry to high-end, intelligent transformation.
, in fact, in recent years, with the enhancement of the sense of independent innovation of domestic enterprises, many enterprises are moving towards high-end areas.
For example, in order to break the long-term monopoly of the valve array multi-unit ion exchange system by foreign enterprises, some domestic enterprises have carried out long-term research and development and innovation, improve equipment performance, the system can save 50% of energy consumption compared to traditional equipment, and the high concentration of feed, save steam, for pharmaceutical companies in terms of energy conservation and environmental protection has brought the gospel.
2020 Shanghai Biofermentation Exhibition, there are also plans to open up some new markets to higher-end areas.
For example, some bio-equipment suppliers say the monoclonal antibody industry has boomed in the past two years, and that almost all of the equipment used in the industry is now dependent on imports, and the company has set itself the goal of replacing imported products with domestic equipment it produces over a period of 5-10 years.
in general, medicine as a new need, with the aging of the population, the incidence of chronic diseases, as well as the upgrading of the level of mass consumption, the future demand for pharmaceutical products will continue to expand, will indirectly drive the expansion of demand for pharmaceutical production equipment, domestic pharmaceutical equipment industry has a huge space for development.
at the same time, with the pharmaceutical equipment enterprises and the industry's continuous efforts to break through the development bottleneck, the future development of equipment localization will accelerate, and further in the high-end areas to achieve import substitution.